Elevation Oncology
(NASDAQ) ELEV
Elevation Oncology Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$38.00K
Net Income (TTM)
$47.99M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ELEV News
ELEV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Elevation Oncology
Industry
Biotechnology
Sector
Health CareEmployees
34
CEO
Joseph J. Ferra, Jr., MBA
Website
www.elevationoncology.comHeadquarters
Boston, NY 10106, US
ELEV Financials
Key Financial Metrics (TTM)
Gross Margin
24%
Operating Margin
-1002%
Net Income Margin
-988%
Return on Equity
-64%
Return on Capital
-49%
Return on Assets
-46%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$24.00K
Operating Income
$44.70M
EBITDA
$44.70M
Operating Cash Flow
$36.36M
Capital Expenditure
$0.00
Free Cash Flow
$36.36M
Cash & ST Invst.
$93.18M
Total Debt
$31.13M
Elevation Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$5.00K
+50.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
34
N/A
Net Income
$14.21M
-32.7%
EBITDA
$14.22M
-44.2%
Quarterly Fundamentals
Net Cash
$49.41M
-32.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$31.25M
+1.4%
Short Term Debt
$0.00
N/A
Return on Assets
-45.64%
N/A
Return on Invested Capital
-48.84%
N/A
Free Cash Flow
$12.71M
-32.8%
Operating Cash Flow
$12.71M
-32.8%